S Adenosylmethionine

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
3
Deaths Reported
3000.0%
Death Rate

Active Ingredients

S Adenosylmethionine

Administration Routes

OralUnknown

Species Affected

Dog 10

Most Affected Breeds

Spaniel - Springer English 3
Weimaraner 3
Shepherd Dog - German 2
Spaniel - King Charles Cavalier 1
Bulldog - French 1

Most Reported Reactions

Bumping into walls 3
Polydipsia 3
Not eating 3
Dilated pupils 3
Abnormal pupil light reflex 3
Blindness 3
Hypertension 3
Paralysis 3
Unable to rise 3
Death by euthanasia 3
Ataxia 2
Diarrhoea 2

Outcome Breakdown

Ongoing
5 (50.0%)
Euthanized
3 (30.0%)
Recovered/Normal
2 (20.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 3
Case-fatality rate (reported events) 3000.0%
Distinct species in reports 1
Distinct breeds in reports 5
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

S Adenosylmethionine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing S Adenosylmethionine, including 3 reports in which the animal died — a 3000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: S Adenosylmethionine. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in S Adenosylmethionine reports are Dog (10 reports), with Dog accounting for the largest share. Within those species, Spaniel - Springer English (3), Weimaraner (3), Shepherd Dog - German (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with S Adenosylmethionine are Bumping into walls (3), Polydipsia (3), Not eating (3), Dilated pupils (3). Of the 10 reports with a coded outcome, Ongoing is the leading category at 50.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on S Adenosylmethionine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial